Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps

List view / Grid view

Ioannis Papayannopoulos

 

Characterising therapeutic antibodies and ADCs using mass spectrometry
Characterising therapeutic antibodies and ADCs using mass spectrometry
article

Characterising therapeutic antibodies and ADCs using mass spectrometry

Since the 1970s, the advent of biotechnology has resulted in…

24 August 2016 | By

Since the 1970s, the advent of biotechnology has resulted in the development and commercialisation of many therapeutic proteins, including antibodies and antibody fragments, for the treatment of human diseases. Examples include antibody treatments for autoimmune diseases (for example, adalimumab [Humira®] for rheumatoid arthritis), cancers (such as trastuzumab [Herceptin®] for breast…

Mass Spectrometry In-Depth Focus 2014
Mass Spectrometry In-Depth Focus 2014
article

Mass Spectrometry: In-Depth Focus 2014

In this free-to-view Mass Spectrometry In-Depth Focus: Some tricks and…

15 April 2014 | By

In this free-to-view Mass Spectrometry In-Depth Focus: Some tricks and tools for structural characterisation of natural products using Electrospray mass spectrometry, Mass spectrometry in the biopharmaceutical industry: from the mundane to the cutting edge, and Mass Spectrometry roundtable...